These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37637068)

  • 41. MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor.
    Zhou Y; Wang M; Shuang T; Liu Y; Zhang Y; Shi C
    Pathol Res Pract; 2019 Oct; 215(10):152606. PubMed ID: 31500928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD44 and EpCAM: cancer-initiating cell markers.
    Marhaba R; Klingbeil P; Nuebel T; Nazarenko I; Buechler MW; Zoeller M
    Curr Mol Med; 2008 Dec; 8(8):784-804. PubMed ID: 19075676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The art of introducing clean intermittent catheterization: How families respond and adapt: A qualitative study.
    Bauer SB; Saunders RA; Masoom SN; Choung K; Hayes LC; Price DE; Keays M; Sable PE; Shimmel A
    Neurourol Urodyn; 2023 Jan; 42(1):309-321. PubMed ID: 36352775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
    Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
    Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
    Tomasević Z; Jelić S
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy.
    Rai S; Mody RN
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S116-22. PubMed ID: 22322729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas.
    Graham C; Chilton-MacNeill S; Zielenska M; Somers GR
    Hum Pathol; 2012 Feb; 43(2):180-9. PubMed ID: 21813156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.
    Iaffaioli RV; Bianchin A; Ruggiero G; Pirozzi G; Ungaro A; Totaro G; Gallo C; De Placido S; Pagliarulo C; Bianco AR
    Oncology; 1988; 45(5):337-43. PubMed ID: 3412739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.
    Albini A; Bruno A; Gallo C; Pajardi G; Noonan DM; Dallaglio K
    Connect Tissue Res; 2015; 56(5):414-25. PubMed ID: 26291921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distinct histologic and genetic characteristics of round cell sarcoma with CIC-DUX4 fusion and comparison with ewing sarcoma.
    Song MJ; Cho KJ; Kim TI; Kim W; Song JS
    Pathol Res Pract; 2022 Mar; 231():153779. PubMed ID: 35151033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L.
    Wong D; Sogerer L; Lee SS; Wong V; Lum A; Levine AB; Marra MA; Yip S
    BMC Biol; 2020 Oct; 18(1):154. PubMed ID: 33115448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target.
    Darabi S; Xiu J; Samec T; Kesari S; Carrillo J; Aulakh S; Walsh KM; Sengupta S; Sumrall A; Spetzler D; Glantz M; Demeure MJ
    Med Oncol; 2023 Jun; 40(7):197. PubMed ID: 37291277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Kito F; Sei A; Sugaya J; Nakagawa M; Yoshida A; Iwata S; Kawai A; Kondo T
    Hum Cell; 2020 Apr; 33(2):427-436. PubMed ID: 31898195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.
    Chebib I; Jo VY
    Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CIC, a gene involved in cerebellar development and ErbB signaling, is significantly expressed in medulloblastomas.
    Lee CJ; Chan WI; Scotting PJ
    J Neurooncol; 2005 Jun; 73(2):101-8. PubMed ID: 15981098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-grade undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: emerging entities of soft tissue tumors with unique histopathologic features--a case report and literature review.
    Haidar A; Arekapudi S; DeMattia F; Abu-Isa E; Kraut M
    Am J Case Rep; 2015 Feb; 16():87-94. PubMed ID: 25683183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High Frequency of Cell-in-Cell Formation in Heterogeneous Human Breast Cancer Tissue in a Patient With Poor Prognosis: A Case Report and Literature Review.
    Ruan B; Niu Z; Jiang X; Li Z; Tai Y; Huang H; Sun Q
    Front Oncol; 2019; 9():1444. PubMed ID: 31921689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours.
    von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; Litvinov SV; van Kamp GJ; Meijer S; Vermorken J; Hilgers J
    Eur J Cancer; 1996 Jul; 32A(8):1325-31. PubMed ID: 8869094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.
    Specht K; Sung YS; Zhang L; Richter GH; Fletcher CD; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jul; 53(7):622-33. PubMed ID: 24723486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.